Bridgewater Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,635	Closed	-$509K	–	779
2023 Q4	$509K	Sell	10,635 -754	-7%	-$36.1K	﹤0.01%	704
2023 Q3	$406K	Sell	11,389 -573	-5%	-$20.4K	﹤0.01%	707
2023 Q2	$552K	Sell	11,962 -1,706	-12%	-$78.7K	﹤0.01%	640
2023 Q1	$548K	Buy	+13,668	New	+$548K	﹤0.01%	640